Comparison of surgical procedures for benign prostatic hyperplasia of medium-volume prostates: evaluation of the causes of rehospitalization from the French National Hospital Database (PMSI-MCO).

Date publication

août 2023

Journal

World journal of urology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ESCHWEGE Pascal , Pr HUBERT Jacques

Tous les auteurs :
Behr A, Salleron J, Mazeaud C, Larose C, Dagry A, Balkau B, Hubert J, Eschwège P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37550549

Résumé

In France, transurethral resection of the prostate (TURP) is still the most commonly used surgical treatment for medium sized benign prostatic hyperplasia (BPH), but the Holmium Laser Enucleation of the Prostate (HoLEP) and laser vaporization procedures are becoming more common. For these three surgical procedures, we evaluate the initial complications, the short term (3 months) and the 4-12-month postoperative complications necessitating re-hospitalization.

Mots clés

Benign prostatic hypertrophy, Holmium Laser Enucleation of the Prostate, Laser vaporization, Transurethral resection of the prostate

Référence

World J Urol. 2023 08 7;: